Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02205021 · ClinicalTrials.gov registry record
Neck Fat Accumulation and Its Relationship to Cardiovascular Risk and Metabolic Syndrome
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 303
- Enrollment target
NCT02205021: Completed study, sponsored by Massachusetts General Hospital.
NCT02205021 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 303 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02205021 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 303 participants
- Enrollment target
Study Summary
Accumulation of fat in the neck using tape measures has been linked to increased cardiovascular risk. The investigators' hypothesis is that detailed measures of neck fat using computed tomography will show that specific fat compartments in the neck contribute differently to cardiovascular risk.
Primary Outcome
Cardiovascular risk measures were obtained within one year of CT imaging of the neck.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 303 participants |
| Start Date | 2014-01 |
What the finished NCT02205021 record still lists
NCT02205021 is an observational study that tracks outcomes without assigning an intervention. The registered 303 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT02205021 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02205021 about?
NCT02205021 is a clinical study titled "Neck Fat Accumulation and Its Relationship to Cardiovascular Risk and Metabolic Syndrome". Accumulation of fat in the neck using tape measures has been linked to increased cardiovascular risk. The investigators' hypothesis is that detailed measures of neck fat using computed tomography will show that specific fat compartments in the neck contribute differently to cardiovascular risk.
What is the current status of trial NCT02205021?
This trial is currently completed. The enrollment target is 303 participants. The study started on 2014-01.
What interventions are being tested in trial NCT02205021?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT02205021?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
- NCT04750616 · 304 participants · Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
- NCT04994717 · 304 participants · Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
- NCT06036147 · 304 participants · NA
Concussion Health Improvement Program
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia